The study, funded by the National Institute of Health and Care Research Bristol Biomedical Research Centre (NIHR Bristol BRC), is one of the first to look at these issues and see what patients are told about new surgical techniques. While surgical innovation is critical to improving outcomes, an independent safety study led by Baroness Cumberlege found that patients may not be receiving all of the information they require prior to having new treatments. According to current recommendations, patients should be provided adequate information by the surgeons to properly weigh the risks and advantages of a new procedure.
The study team examined consultations between surgeons and patients in which new procedures were discussed in order to analyze current practice. They concentrated on seven different procedures being implemented in five NHS institutions. In addition, nine clinicians performing novel procedures were interviewed about what they wished to tell patients.
Researchers discovered that practitioners intended to convey the novel nature of the procedures but acknowledged that these discussions sometimes be difficult. The researchers audio-recorded 37 meetings between clinicians and patients in which novel procedures were mentioned.
Only a minority of clinicians clearly mentioned the procedure as innovative, their limited expertise with it, a lack of proof, and doubt regarding the outcome. The study also found that while all practitioners were excited about the benefits of a new type of operation, they frequently failed to disclose the possible hazards.
Thirty post-operative interviews with patients were then undertaken. This was done by researchers to learn what patients thought about the information they were given.
Patients had a great sense of trust in their clinicians and were reassured by their confident demeanor. They also picked up on clinicians’ enthusiasm for operations they saw as “future-proof.” Many people believed the procedures were more established than they were, and they felt they were not informed about the potential downsides of undergoing the new operation.
Dr Daisy Elliott, lead author and Research Fellow in the Bristol Medical School: Population Health Sciences (PHS), said: “This study provides important insights into the communication process surrounding innovative surgical procedures and devices. Despite the clinicians’ best intentions, many patients weren’t fully informed about innovative procedures. Whilst there is often a belief that ‘new is better’, this research highlights that clinicians can find it difficult to provide neutral and balanced information in this context. A major focus of our work at the Bristol BRC will be to work with clinicians to provide support and training, so that patients can make well informed decisions about undergoing new procedures.”
Paula Goss, founder of Rectopexy mesh victims and support and ambassador for Mesh UK, added: “Fully informed consent discussions are crucial for patient safety for all procedures. Consultants and nurses should speak to patients thoroughly and transparently, allow recording of the consultations for patients to think about the information provided, and patients should be able to continue a dialogue to ask any question before any procedure. This should be a mandatory requirement for all hospitals and healthcare settings. Thorough in-depth patient involvement at every stage is the only way to provide and correct the issue of lack of trust that arises commonly with patients about to undergo any procedure.”
Jane Blazeby, Professor of Surgery in the Bristol Medical School: (PHS) and project lead, said: “To our knowledge this is the first time that conversations between clinicians and patients discussing innovative surgical procedures have been investigated. It highlights the need for a standard approach that provides clear and unbiased information for patients. This is our next plan to improve this process to benefit patients, surgeons and the NHS.”
more recommended stories
-
AI Uncovers Hidden Pregnancy Risks for Stillbirth
A groundbreaking AI-driven study has identified.
-
Harvard Study Unveils New TB Drug Regimens
A Harvard Medical School-led clinical trial.
-
Chemotherapy Side Effect: Chronic Nerve Pain in 40%
A recent global study published in.
-
Largest Cannabis Brain Study Finds Memory Impairment
New Study Reveals Cannabis’ Impact on.
-
How Long to Form a Habit? Study Reveals Surprising Insights
A recent systematic review published in.
-
Carnivore Diet-Induced Cholesterol Deposits Alarm Doctors
Man on High-Fat Carnivore Diet Develops.
-
Endometriosis: A Hidden Risk for Heart Disease
A recent study published in BMC.
-
Hepatitis B Reactivation: 2025 Guideline Updates
Recent advancements in immunosuppressive therapies necessitated.
-
Heart Failure Risk Cut Post-Attack with PR-364 Drug
Researchers at Cedars-Sinai Medical Center have.
-
PTSD, Anxiety Linked to Lower Ovarian Reserve in Firefighters
A recent study by the University.
Leave a Comment